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Objectives: To evaluate the interobserver reliability of echocardiographic findings of right ventricle (RV) dysfunction
for prognosticating normotensive patients with pulmonary embolism (PE).
Methods: A central panel of cardiologists evaluated echocardiographic studies of 75 patients included in the
PROTECT study for the following signs: RV diameter, RV/left ventricular (LV) diameter ratio, hypokinesis of the RV
free wall, and tricuspid plane systolic excursion (TAPSE). Investigators used intraclass correlation to assess
agreement between the measurements of the central panel and each of the local cardiologists. Investigators used
the single weighted kappa statistic to test for agreement between readers of interpretation of RV enlargement and
RV hypokinesis.
Results: The two observers had fair agreement (k = 0.45) for RV enlargement assessed by the RV diameter, and
good agreement (k = 0.65) for RV enlargement assessed by the RV/LV diameter ratio. The interobserver reliability of
the assessment whether hypokinesis of the RV free wall is present was good (к = 0.70), and whether RV dysfunction
(assessed by TAPSE measurement) is present was very good (k = 0.86). The intraclass correlation for the RV/LV
diameter ratio was fair (0.55; 95% confidence interval [CI], 0.37-0.69), for the RV diameter was good (0.70; 95% CI,
0.56-0.80), and for the TAPSE measurement was very good (0.85; 95% CI, 0.77-0.90). On Bland-Altman analysis, the
mean differences for RV diameter, RV/LV diameter ratio and TAPSE measurement were 2.33 (±5.38), 0.06 (±0.23) and
0.08 (±2.20), respectively.
Conclusion: TAPSE measurement is the least user dependent and most reproducible echocardiographic finding of
RV dysfunction in normotensive patients with PE.
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Acute pulmonary embolism (PE) is a common disease
with a 3-month mortality rate of up to 17.4% [1-4]. Even
if PE is properly treated with anticoagulation, the mor-
tality rate in hemodynamically stable patients varies
from 8.1% to 15.1% [4,5]. Death is usually caused by
acute right heart failure [4-9]. Acute PE increases the
pressure of the pulmonary arterial system and right* Correspondence: djc_69_98@yahoo.com
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unless otherwise stated.ventricle (RV) resulting in RV dysfunction, which may
progress to right heart failure and circulatory collapse
[5,6]. Patients with RV dysfunction have a higher mortal-
ity rate than those without, even if they are initially
hemodynamically stable [6,7]. Thus, the presence of RV
dysfunction is a marker for adverse clinical outcome in
patients with acute PE [6-8].
Transthoracic echocardiography (TTE) is the most
common first-line examination to diagnose the signs of
RV dysfunction [6-9]. Echocardiography is capable of
visualizing the changes occurring in the morphology and
function of the right ventricle as a result of acuteal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Baseline characteristics for normotensive patients
with acute symptomatic pulmonary embolism
All patients
N = 73
Clinical characteristics, n (%)
Age, years, median (25th-75th percentiles) 70 (59–79)
Male gender 39 (53%)
Risk factors for VTE, n (%)
Cancer† 9 (12%)
Recent surgery‡ 4 (5.5%)
Immobilizationy 25 (34%)
Comorbid diseases, n (%)
COPD 14 (19%)
Congestive heart failure 3 (4.1%)
Clinical symptoms and signs at presentation, n (%)
Syncope 16 (22%)
Chest pain 38 (52%)
Dyspnea 54 (74%)
Heart rate > 100/minute 20 (27%)
Arterial oxyhemoglobin saturation (SaO2) < 90% 16 (22%)
SBP < 120 mm Hg 18 (25%)
Concomitant DVT 35 (48%)
Abbreviations: VTE venous thromboembolism, COPD chronic obstructive
pulmonary disease, SBP systolic blood pressure, DVT deep vein thrombosis.
†Active or under treatment in the last year.
‡In the previous month.
yImmobilized patients are defined in this analysis as non-surgical patients who
had been immobilized (i.e., total bed rest with bathroom privileges) for ≥4 days
in the month prior to PE diagnosis.
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assessment of RV dysfunction on TTE have been pro-
posed and the literature shows variable results for the
prognostic power of TTE signs of RV dysfunction to
predict adverse outcomes [10]. This variability may in
part be explained by the somewhat subjective nature of
diagnosing RV dysfunction on TTE because formal cri-
teria for establishing these signs are not available. It is
noteworthy that prior publications on this topic did not
report interobserver reproducibility of the findings.
Accordingly, the purpose of our study was to determine
the interobserver reproducibility of TTE findings previously
described to indicate RV dysfunction with the goal of iden-
tifying the most robust, least observer dependent method.
Methods
Study design
This was a sub analysis of the first 75 patients enrolled in
the PROTECT, a prospective, multicenter observational
cohort study designed by the authors (see Appendix) and
sponsored by the Institute of Health Carlos III, Spain
(NCT00880737) [11]. Local ethics committees approved
the study. All patients provided written informed consent.
Patients
Only patients diagnosed with pulmonary embolism by
multidetector CT were eligible [12]. Exclusion criteria
consisted of treatment with thrombolytics at the time of
PE diagnosis, life expectancy less than 3 months, preg-
nancy, geographic inaccessibility precluding follow-up,
age younger than 18 years, renal insufficiency (creatinine
clearance < 30 mL/min), inability to complete CT testing
(e.g., allergy to intravenous contrast agents, unavailability
of CT, patient too ill), or hemodynamic instability at pres-
entation (defined as cardiogenic shock, systolic blood
pressure < 90 mmHg, or use of inotropic support). We
also excluded patients that did not successfully complete
the protocol-required transthoracic echocardiography.
Examinations
The study required that patients undergo echocardiog-
raphy (i.e., TTE) within 24 hours after diagnosis of PE.
Patients underwent testing in the left lateral position.
Trained and certified local cardiologists, blinded to the
patient’s clinical data and laboratory test results, per-
formed and interpreted each echocardiogram. This sub
study defined echocardiographic RV dysfunction as the
presence of dilatation of the right ventricle (end-diastolic
diameter > 30 mm from the parasternal view or the right
ventricle appearing larger than the left ventricle from the
subcostal or apical view), hypokinesis of the right ventricle
free wall (any view), or a tricuspid plane systolic excursion
(TAPSE) of 1.6 cm or less. TAPSE was measured as the
total displacement of the tricuspid annulus (centimeters)from end-diastole to end-systole, with values representing
the average TAPSE of three to five beats [13].
Local cardiologists recorded all examinations on digital
format for off-line blinded re-evaluation by one of the
echocardiographers from the central panel (S.B., M.R.
and H.C.) (25 studies each).
Statistical analyses
This sub study assessed interobserver reproducibility by
the intraclass correlation coefficient and Bland-Altman
analysis [14]. For the presence or absence of RV dys-
function, the study assessed interobserver reproducibility
using weighted kappa measurement. The kappa value for
agreement was interpreted as follows: poor, < 0.20; fair,
0.21–0.40; moderate, 0.41–0.60; good, 0.61–0.80; and
very good, 0.81–1.00 [15].
Statistical significance was defined as a two-tailed P-value
of <0.05 for all analyses. Analyses were performed using
SPSS, version 15.0 for the PC (SPSS, Inc. Chicago, IL, USA).
Results
Transthoracic echocardiography was technically inad-
equate in 2 of the 75 patients who were enrolled in this
















































Figure 1 Bland-Altman analysis of RV end-diastolic diameter measured by two cardiologists. Abbreviations: RVEDD, right ventricle end-diastolic
diameter; SD, standard deviation.
Table 2 Interobserver variability for the presence of
RV dysfunction (defined as a RV end-diastolic















RV dysfunction (n) 14 30 44
Total (n) 37 36 73
Abbreviations: RV right ventricle.
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6.3%). The median age was 70 years (interquartile range
[IR], 59–79), and 47% of patients were female (Table 1).
According to the local cardiologists’ measurements, the
RV end-diastolic diameter was > 30 mm in 60% of pa-
tients (44/73). In 22% (16/73) of patients, the ratio of the
RV to the LV short axis was greater than 1, and 11% of
patients had a TAPSE of 1.6 cm or less.
RV end-diastolic diameter
The mean RVD end-diastolic diameter from the para-
sternal view measured by local and central cardiologist
were 3.3 ± 0.7 cm and 3.1 ± 0.6 cm, respectively. The
intraclass correlation was good (0.70; 95% CI, 0.56-0.80).
On Bland-Altman analysis of RV end-diastolic diameter
measurements, the means and standard deviation (SD)
between central and local cardiologists were 2.33 and
5.38, respectively (Figure 1). When RV dysfunction was
defined as a RV end-diastolic diameter > 30 mm from
the parasternal view, the two observers agreed that in 23
patients (32%; 95% CI, 21-42%) no RV dysfunction was
present. The two observers agreed that RV dysfunction
was present in 30 patients (41%; 95% CI, 30-52%); dis-
agreement whether residual occurred in 20 patients
(27%; 95% CI, 17-38%) (Table 2). The interobserver
agreement whether RV dysfunction is present or not is
fair, with a weighted kappa of 0.45 (95% CI, 0.25-0.65).
Ratio of the RV to the LV short axis
The mean RV to left ventricle ratios were 0.83 ± 0.28 for
local and 0.88 ± 0.20 for central cardiologist, respectively.
The intraclass correlation was fair (0.55; 95% CI, 0.37-0.69).On Bland-Altman analysis of RV/LV ratio measurements,
the means and standard deviation (SD) between central
and local cardiologists were 0.06 and 0.23, respectively
(Figure 2). For the ratio of the RV to the LV short axis
the observers agreed that 52 patients (71%; 95% CI, 61-82%)
were free of RV dysfunction. They agreed upon the
presence of RV dysfunction in 12 patients (16%; 95%
CI, 7.9-25%). Disagreement existed in 9 patients (12%;
95% CI, 4.8-20%) (Table 3). The interobserver agreement
reflecting the presence or absence of RV dysfunction was
good with a weighted kappa of 0.65 (95% CI, 0.44-0.86).
Hypokinesis of the RV free wall
The observers agreed that 55 patients (75%; 95% CI; 65-
85%) were free of hypokinesis of the RV free wall. They
agreed upon the presence of RV free wall hypokinesis in
11 patients (15%; 95% CI, 6.9-23%). Disagreement existed
in 7 patients (9.6%; 95% CI, 2.8-16%) (Table 4). The inter-
observer agreement reflecting the presence or absence of






















































Figure 2 Bland-Altman analysis of ratio of the RV to the LV short axis measured by two cardiologists. Abbreviations: RVD, right ventricle
diameter; LVD, left ventricle diameter; SD, standard deviation.
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of 0.70 (95% CI, 0.50 to 0.91).TAPSE
The mean TAPSE measured by local and central cardiolo-
gist was 2.1 ± 0.4 cm and 2.1 ± 0.4 cm, respectively. The
intraclass correlation for the TAPSE measurement was
very good (0.85; 95% CI, 0.77-0.90). On Bland-Altman
analysis of TAPSE measurements, the means and standard
deviation (SD) between central and local cardiologists
were 0.08 and 2.20, respectively (Figure 3). When RV dys-
function was defined as a TAPSE of 1.6 cm or less, the
two observers agreed that in 64 patients (88%; 95% CI, 80-
95%) no RV dysfunction was present. The two observers
agreed that RV dysfunction was present in 7 patients
(9.6%; 95% CI, 2.8-16%); disagreement whether residual
occurred in 2 patients (2.7%; 95% CI, 0–6.5%) (Table 5).
The interobserver agreement whether RV dysfunction isTable 3 Interobserver variability for the presence of RV
dysfunction (defined as a RV appearing larger than the















RV dysfunction (n) 4 12 16
Total (n) 56 17 73
Abbreviations: RV right ventricle.present or not is very good, with a weighted kappa of 0.86
(95% CI, 0.67 to 1).
Discussion
In this study, we aimed at analyzing the observer depend-
ence of establishing the echocardiographic signs of RV dys-
function that have hitherto been described in the literature
to identify the most robust and reproducible method. Our
results suggest that considerable interindividual differences
exist in the reproducibility of echocardiographic signs of
RV dysfunction. TAPSE measurement is the least user
dependent and most reproducible.
Studies have recognized RV dysfunction as a key de-
terminant of prognosis in PE [16]. Echocardiographic
findings suggesting RV dysfunction have been reported
to occur in at least 25% of PE patients [17]. A meta-
analysis found more than a two-fold increased risk of
PE-related mortality in patients with echocardiographic
signs of RV dysfunction [18]. Two out of the seven stud-
















RV dysfunction (n) 3 11 14
Total (n) 58 15 73
Abbreviations: RV right ventricle.



















































Figure 3 Bland-Altman analysis of TAPSE measured by two cardiologists. Abbreviations: TAPSE, tricuspid annular systolic excursion; SD,
standard deviation.
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had sensitivity of 56–61% and was related to the abso-
lute increase in the early PE-related mortality of 4–5%
[18]. Importantly, patients with normal echocardiographic
findings had an excellent outcome, with in hospital PE-
related mortality less than 1% in most of the reported
series [6,7,19]. The most important limitations are the lack
of standardization of the echocardiographic criteria [10],
and the somewhat subjective nature of diagnosing RV dys-
function on pulmonary echocardiography.
Our results show that the interobserver reliability was
higher for qualitative abnormalities on transthoracic
echocardiography (i.e., hypokinesis of the RV free wall).
There are several potential explanations for these find-
ings. Moderate or severe RV dysfunction is usually iden-
tified qualitatively, and it is ordinarily readily apparent to
observers even with only modest experience [8]. More-
over, RV dimensions are highly dependent on probe rota-
tion by the user, which can result in an underestimation ofTable 5 Interobserver variability for the presence of RV















RV dysfunction (n) 1 7 8
Total (n) 65 8 73
Abbreviations: RV right ventricle.RV width [20]. For normotensive patients with acute
symptomatic PE, TAPSE is independently predictive of
survival [21]; however no studies had previously assessed
interobserver reliability for this parameter in these pa-
tients. In the initial validation study by Kaul et al. [22],
TAPSE correlated strongly with radionuclide angiography,
with low interobserver variability. For PE patients, our re-
sults confirm that interobserver variability for TAPSE
measurements was very low and lower than for all other
echocardiographic signs of RV dysfunction investigated
here.
The findings of this study might have clinical implica-
tions. Some authors have proposed that normotensive
patients with RV dysfunction on echocardiography
should potentially undergo thrombolytic therapy [23].
This study detected only fair reproducibility of the RV
end-diastolic diameter and the RV diameter/left ven-
tricular diameter ratio. Thus, findings from this study do
not adequately justify use of these parameters to drive
decision-making regarding thrombolytic therapy.
Besides the fact that this study is the first study to re-
port upon the clinical implication of interobserver reli-
ability on the measurement of echocardiographic RV
dysfunction in normotensive patients with acute PE, this
study has other strengths. Particularly, this is the first
study that reports on the interobserver reliability of
TAPSE. Our study has several limitations. We were not
able to assess the interobserver reproducibility of systolic
pulmonary pressure and other echocardiographic criteria
for RV dysfunction (e.g., systolic excursion velocity of
the tricuspid annulus). Though with 3D echocardiog-
raphy there is less underestimation of RV end-diastolic
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ability compared with 2D echocardiography [24], investi-
gators did not perform volumetric analyses of the RV.
Furthermore, our results should be interpreted with cau-
tion due to the limited sample size.
In conclusion, this is the first study that systematically
assessed the interobserver reliability of echocardiographic
findings of RV dysfunction in normotensive patients with
acute PE. We found considerable differences in the inter-
observer reproducibility of these findings. TAPSE measure-
ment is the least user dependent and most reproducible. If
these signs are used in clinical practice to make patient
management decisions, practitioners should be aware
of the variable degree of subjectivity and reproducibil-
ity associated with these observations.
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